BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 1999
View Archived Issues
Bayer describes new oxazolidinone antibacterials in recently issued patent
Read More
Dihydropyridines from Pfizer show excellent bradykinin-antagonist effects
Read More
New benzimidazoles useful in the treatment of diabetes and its complications under study at ADIR
Read More
9a-Azalides with potent antibacterial activity in development at Merck
Read More
Pharmacia & Upjohn describes new triazinic compounds with multiple pharmacological effects
Read More
AMPA receptor antagonists in the pipeline at Schering
Read More
Pharmacological characterization of fluodipine: a new selective bradycardic agent
Read More
New AIDS vaccine expected to begin clinical trials later this year
Read More
Ziagen introduced by Glaxo Wellcome as new HIV treatment option
Read More
Vanguard Medica and Elan seek regulatory approval of Miguard in the U.S.
Read More
Beneficial vascular effects of estrogen therapy in hypercholesterolemic postmenopausal women
Read More
NeuroSearch commences phase II clinical trials of potential antidepressant
Read More
Ilex Oncology adds Canadian trial site to intoplicine development
Read More
Phase I clinical trial commences in Germany for insomnia compound
Read More
IND for MRE-0470 approved by FDA
Read More
First NDA filing for Prevatac expected to be delayed
Read More
AxyS and Protein Design Labs enter drug discovery agreement
Read More
Nexell acquires most CellPro assets and forms new diagnostics division
Read More
Sonus and Abbott amend EchoGen agreements
Read More
Proteasome inhibitors show potential in inflammatory disorders
Read More
Coulter: Q4 and FY 1998 highlights
Read More
Titan completes private placement, updates R&D progress
Read More